Connexins as therapeutic targets in lung disease
Authors:
- Davide LosaDLDavide Losa
- Marc ChansonMCMarc Chanson
- Sophie CrespinSCSophie Crespin
- 17 May 2011
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Targets
- Vol. 15 (8) , 989-1002
Abstract
(2011). Connexins as therapeutic targets in lung disease. Expert Opinion on Therapeutic Targets: Vol. 15, No. 8, pp. 989-1002. doi: 10.1517/14728222.2011.584875Keywords
This publication has 104 references indexed in Scilit:
- Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertensionRespiratory Research, 2011
- Prostaglandin E2 Regulation of Cystic Fibrosis Transmembrane Conductance Regulator Activity and Airway Surface Liquid Volume Requires Gap Junctional CommunicationAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Pathophysiology of bronchial smooth muscle remodelling in asthmaEuropean Respiratory Journal, 2010
- Receptor‐promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotidesThe Journal of Physiology, 2010
- Pannexin 1 Contributes to ATP Release in Airway EpitheliaAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Thrombin Promotes Release of ATP from Lung Epithelial Cells through Coordinated Activation of Rho- and Ca2+-dependent Signaling PathwaysJournal of Biological Chemistry, 2009
- Purinergic receptors in airway epitheliaCurrent Opinion in Pharmacology, 2009
- Cross-Talk Between Pulmonary Injury, Oxidant Stress, and Gap Junctional CommunicationAntioxidants & Redox Signaling, 2009
- Connexin and pannexin mediated cell–cell communicationNeuron Glia Biology, 2007
- Connexin 43 mediates spread of Ca2+ -dependent proinflammatory responses in lung capillariesJournal of Clinical Investigation, 2006